Functional Mushroom Supplements Are Booming. Most Beta-Glucan Claims Don't Hold Up to Testing.

The functional mushroom supplement market is, by any measure, one of the fastest-growing segments in natural products right now. Lion’s mane for cognitive support. Reishi for immune modulation. Chaga for antioxidant activity. Turkey tail for gut health. These aren’t fringe ingredients anymore — they’re mainstream SKUs at every major natural products retailer, and wholesale raw material demand from Midwest supplement brands has roughly doubled over the past three years.

But here’s the problem that keeps surfacing when batches come through our Chicago receiving hub: the beta-glucan numbers on incoming COAs frequently don’t match what the testing shows.

This isn’t always fraud. Sometimes it’s a genuine misunderstanding of how polysaccharide assays work. Sometimes it’s suppliers using total polysaccharide methods that can’t distinguish fungal beta-glucans from grain starch. Sometimes it’s a fundamental mislabeling of what substrate the mushroom was actually grown on. The cause varies. The result doesn’t: your finished product doesn’t contain what your label claims. And under DSHEA, that’s squarely your liability.

The Mycelium-on-Grain Problem Nobody in the Supply Chain Wants to Discuss

Most functional mushroom raw material entering the US market is produced in China — primarily in Zhejiang, Fujian, and Yunnan provinces — and a significant portion of it is mycelium grown on cereal grain substrates, typically oats, rice, or wheat, rather than fruiting bodies harvested from wood or sawdust.

The distinction matters for one specific reason: the grain substrate doesn’t fully degrade during the fermentation process. When you grind and powder the mycelium biomass, you’re also grinding up residual starch. Starch is a polysaccharide. If your supplier runs a total polysaccharide assay — which many do, because it’s inexpensive and produces numbers that look impressive on a spec sheet — you’ll see a polysaccharide percentage in the 30–50% range that has nothing meaningful to do with fungal beta-glucans.

Fungal beta-glucans are (1,3)/(1,6)-linked glucose polymers derived from the fungal cell wall. They’re the bioactive fraction documented in peer-reviewed clinical literature for immune-modulating activity. Cereal starch is predominantly (1,4)-linked alpha-glucan — a structurally and biochemically different molecule. When an enzymatic or colorimetric total polysaccharide test lumps both together, the starch fraction inflates the reported number every time.

Distinguishing between them requires an assay specific to mixed-linkage (1,3)/(1,6)-beta-D-glucan. The Megazyme enzymatic method (catalog K-MBGL) is the closest thing the industry currently has to a defensible standard for mushroom materials. When that specific assay is run on samples arriving with COAs claiming 30% beta-glucan content, actual fungal beta-glucan levels in the 8–15% range are not unusual. The remainder is starch from the growth substrate.

A polysaccharide percentage on a COA tells you almost nothing without knowing which assay was used. If your supplier can’t specify the method — total polysaccharide vs. specific beta-glucan — assume the number is inflated.

Species Verification: Why HPTLC and DNA Barcoding Both Have a Role

Identity fraud in the functional mushroom category is less common than the mycelium-on-grain issue, but it exists — and the regulatory consequences are considerably more serious. Selling material sourced from a lower-value species under the label of a premium one is misbranding under 21 CFR Part 101. That’s not a quality variance. It’s a labeling violation, and FDA warning letters have been issued to supplement manufacturers for exactly this.

The analytical challenge is that powdered mushroom extracts are visually indistinguishable. You cannot look at a fine beige or brown powder and determine the genus and species. You need molecular or chemical fingerprinting.

DNA barcoding is the most definitive approach for species-level identification. Genomic DNA is extracted from the raw material, the ITS (internal transcribed spacer) region is amplified by PCR, and the resulting sequence is matched against reference databases — NCBI GenBank and the BOLD Systems database both carry validated fungal ITS reference sequences. A >99% sequence identity to the target species is confirmatory; anything divergent flags a material-level investigation.

One practical limitation: heavily processed hot-water or alcohol extracts can have degraded DNA from the high-temperature extraction. In those cases, sequencing yield is low and results can be inconclusive. This is where HPTLC earns its place in the testing workflow.

HPTLC fingerprinting works on chemical secondary metabolite profiles rather than DNA, so it’s resistant to the DNA degradation issue. Reishi (Ganoderma lucidum) carries characteristic triterpenoid compounds — ganoderic acids — that produce a recognizable fingerprint. Lion’s mane (Hericium erinaceus) has hericenones and erinacines. Chaga (Inonotus obliquus) carries betulinic acid derivatives from its birch tree host. Comparing your raw material’s HPTLC plate against an authenticated reference standard gives a visual and densitometrically quantifiable identity confirmation.

Running both methods in parallel on new supplier relationships is the most defensible approach. DNA barcoding confirms species identity at the molecular level; HPTLC confirms the chemical fingerprint is consistent with what you paid for. Together, they produce the kind of botanical identity documentation that satisfies an FDA GMP inspector’s records request.

What DSHEA Actually Requires — and Where the Exposure Lives

Under the Dietary Supplement Health and Education Act and the 21 CFR Part 111 cGMP regulations, finished product manufacturers are responsible for establishing the identity, purity, strength, and composition of every dietary ingredient in their products. For botanical raw materials, that means identity testing is non-optional.

21 CFR §111.75(a)(1) requires manufacturers to confirm the identity of each component used in manufacturing before use. FDA has cited firms repeatedly during GMP inspections for treating vendor COAs as identity confirmation without any independent testing. The agency’s consistent position — reinforced across multiple warning letters — is that a supplier COA is not a substitute for independent identity testing, either conducted in-house or through a qualified analytical testing laboratory.

This is a meaningful distinction for brands sourcing functional mushroom raw materials. If you’re buying lion’s mane extract from a distributor who is aggregating from multiple growers in Zhejiang Province, the COA that arrived with your pallet reflects whatever that distributor’s supplier tested — not what is actually in your warehouse right now.

The DSHEA exposure around potency claims is equally concrete. If your lion’s mane capsule label states “500 mg standardized to 30% beta-glucan,” that is your legal representation of the product’s composition. If a specific beta-glucan assay shows 9% actual fungal beta-glucan, you have a misbranded product under 21 CFR Part 101.7. The FTC has taken action against functional mushroom brands making unsubstantiated structure/function claims; FDA inspections increasingly include ingredient-level testing, not just document review.

Building a Defensible Incoming QC Panel for Mushroom Raw Materials

For Midwest supplement brands sourcing functional mushroom ingredients, here’s what a defensible incoming quality control program looks like in practice:

Species Identity: HPTLC fingerprinting against authenticated reference material plus ITS-based DNA barcoding. Run both on all new supplier relationships; DNA barcoding alone on subsequent lots once the relationship is established.

Potency Quantification: Megazyme K-MBGL enzymatic assay for fungal (1,3)/(1,6)-beta-D-glucan content. This is the number that actually reflects bioactive content. Total polysaccharide values are marketing data, not quality data.

Alpha-Glucan (Starch) Quantification: Running an alpha-glucan assay alongside beta-glucan lets you calculate the beta-glucan-to-total-polysaccharide ratio. A ratio below 0.5 on material claiming to be a fruiting body extract is a strong signal you’re looking at mycelium biomass with significant grain contamination.

Heavy Metals via ICP-MS: Chaga in particular bioaccumulates metals from its birch tree host. Samples sourced from certain regions carry elevated arsenic and lead levels that reliably exceed USP <232> acceptable daily intake limits for oral supplements. This isn’t hypothetical — it shows up in incoming lot data with enough regularity to make ICP-MS testing non-optional for chaga and any blend containing it.

Microbiology per USP <61>/<62>: Total aerobic count, yeast and mold, E. coli, and Salmonella. Dried botanical materials carry variable bioburden, especially material that transited through high-humidity conditions. A total yeast and mold count above 10³ CFU/g is a formulation risk for many finished product applications.

Water Activity and Moisture: Water activity above 0.65 Aw creates conditions for mold proliferation during storage, which in turn creates mycotoxin risk. For any material stored in a Midwest warehouse through summer months — where ambient humidity can push storage conditions — moisture and water activity testing before and after storage is worth the cost.

None of this needs to happen on every lot from an established, audited supplier. But for any new supplier relationship, and for any material going into a product carrying an explicit beta-glucan potency claim, there’s no defensible shortcut.

Why Lot-to-Lot Variability Is Its Own Red Flag

One pattern we see in the incoming data that doesn’t get discussed enough: high lot-to-lot variability from what appears to be the same supplier. Beta-glucan levels shifting from 22% on one lot to 11% on the next. Metal profiles that change between shipments. HPTLC fingerprints that are similar but not consistent.

This is usually a sign that a distributor is aggregating material from multiple growers rather than sourcing from a single controlled production operation. Vertically integrated mushroom producers — companies that control cultivation through processing — produce far more consistent analytical profiles. Commodity distributors aggregating from a loose network of small-scale growers produce variable ones.

For a brand that has built a label claim around a specific beta-glucan level, lot-to-lot variability isn’t just a quality headache. It’s a labeling and compliance liability that compounds with every new production run.

Working with an analytical testing lab on a supplier qualification program — including an initial full-panel assessment of multiple lots before approving a supplier — gives you the data to make sourcing decisions with actual scientific backing rather than a polished sales pitch and a COA of uncertain provenance.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• Botanical identity testing under ISO 17025 accreditation — HPTLC and DNA barcoding panels — Qalitex Laboratories performs the full botanical identity and analytical testing behind every Ayah Labs CoA, from our ISO 17025-accredited California facility.
• ICP-MS heavy metals testing for supplement raw materials under USP <232>/<233> — Quantitative elemental impurities analysis for botanical ingredients, including mushroom materials with elevated bioaccumulation risk.